Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting.

@article{Serebruany2008IncidenceAC,
  title={Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting.},
  author={Victor L. Serebruany and Ilya Pokov and Wiktor Kuliczkowski and Javad Vahabi and Dan Atar},
  journal={Thrombosis and haemostasis},
  year={2008},
  volume={100 2},
  pages={314-8}
}
The experimental oral antiplatelet agent AZD6140 causes dyspnea in randomized trials. Whether clopidogrel may also cause dyspnea remains controversial. We sought to define the incidence and causes of dyspnea in a large post-percutaneous coronary intervention (PCI) cohort based on open-labeled consecutive registry analysis of in-hospital charts and discharge diagnoses. Data were collected at six-month follow-up by means of telephone interviews or returned questionnaires during outpatient visits… CONTINUE READING